{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:12:11Z","timestamp":1788444731356,"version":"build-2803163510"},"reference-count":30,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    We examined the prognostic value of routine NGS data in newly diagnosed acute myeloid leukemia (AML) treated with intensive (7\u2009+\u20093 backbone) induction, specified by AML subtype. A contemporary (2015\u20132025) series of 545 Mayo Clinic patients (median age 56\u2009years, females 44%) was considered. Median follow\u2010up was 49\u2009months with 341 (63%) allogeneic hematopoietic stem cell transplantations (AHSCT) recorded. AML subtypes included core\u2010binding factor (CBF;\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200972; 13%), primary non\u2010CBF (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u2009403; 74%), post\u2010myelodysplastic syndromes (MDS) or post\u2010myelodysplastic\/myeloproliferative neoplasms (post\u2010MDS\u2010MDS\/MPN;\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200928; 5%), post\u2010MPN (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200915; 3%), and therapy\u2010related (t\u2010AML;\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200927; 5%). Corresponding complete remission rates, with\/without count recovery (CR\/CRi), were 89%, 76%, 64%, 27%, and 78% (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01) and 5\u2010year transplant\u2010censored survival rates 68%, 57%, 21%, 0%, and 55% (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01). In multivariable analyses, the prognostic value of specific mutations was mostly limited to primary non\u2010CBF AML where adverse karyotype (OR 1.9;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.04) predicted inferior and\n                    <jats:italic>FLT3<\/jats:italic>\n                    \u2010ITD (OR 0.4;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01) or\n                    <jats:italic>NPM1<\/jats:italic>\n                    <jats:sup>MUT<\/jats:sup>\n                    \/\n                    <jats:italic>FLT3<\/jats:italic>\n                    <jats:sup>WT<\/jats:sup>\n                    (OR 0.1;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01) superior CR\/CRi while\n                    <jats:italic>KRAS<\/jats:italic>\n                    <jats:sup>MUT<\/jats:sup>\n                    (HR 8.8;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01),\n                    <jats:italic>TP53<\/jats:italic>\n                    <jats:sup>MUT<\/jats:sup>\n                    (HR 5.4;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01), and\n                    <jats:italic>TET2<\/jats:italic>\n                    <jats:sup>MUT<\/jats:sup>\n                    (HR 2.3;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.01) predicted inferior and\n                    <jats:italic>NPM1<\/jats:italic>\n                    <jats:sup>MUT<\/jats:sup>\n                    \/\n                    <jats:italic>FLT3<\/jats:italic>\n                    <jats:sup>WT<\/jats:sup>\n                    (HR 0.3;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.01) superior survival. Prognostication in intensively\u2010treated AML should start with subtype specification and recognition of the limited value of NGS in non\u2010primary AML. Post\u2010MPN AML is particularly associated with dismal outcomes and should be prognostically distinguished from post\u2010MDS\u2010MDS\/MPN AML. In primary non\u2010CBF AML, in addition to previously established risk factors, the favorable impact of\n                    <jats:italic>FLT3<\/jats:italic>\n                    \u2010ITD on achieving CR\/CRi and the unfavorable impact of\n                    <jats:italic>KRAS<\/jats:italic>\n                    <jats:sup>MUT<\/jats:sup>\n                    and\n                    <jats:italic>TET2<\/jats:italic>\n                    <jats:sup>MUT<\/jats:sup>\n                    on transplant\u2010censored survival were noted and require confirmation from additional studies.\n                  <\/jats:p>","DOI":"10.1002\/ajh.70443","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:17:35Z","timestamp":1784366255000},"page":"2509-2519","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute Myeloid Leukemia Subtype\u2010Specific Prognostic Value of\n                    <scp>NGS<\/scp>\n                    in the Setting of Intensive Chemotherapy"],"prefix":"10.1002","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-1954","authenticated-orcid":false,"given":"Abiola","family":"Bolarinwa","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-3715","authenticated-orcid":false,"given":"Aref","family":"Al\u2010Kali","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3609-8404","authenticated-orcid":false,"given":"Hassan B.","family":"Alkhateeb","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-9887","authenticated-orcid":false,"given":"Abhishek A.","family":"Mangaonkar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5134-7336","authenticated-orcid":false,"given":"Antoine N.","family":"Saliba","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8860-3380","authenticated-orcid":false,"given":"Mehrdad Hefazi","family":"Torghabeh","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasiya","family":"Matin","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-9886","authenticated-orcid":false,"given":"Michelle A.","family":"Elliott","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-6302","authenticated-orcid":false,"given":"Mark R.","family":"Litzow","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5841-4105","authenticated-orcid":false,"given":"William J.","family":"Hogan","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5359-336X","authenticated-orcid":false,"given":"Mithun V.","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6998-662X","authenticated-orcid":false,"given":"Mrinal M.","family":"Patnaik","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9084-4148","authenticated-orcid":false,"given":"Animesh","family":"Pardanani","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1673-1708","authenticated-orcid":false,"given":"James M.","family":"Foran","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Jacksonville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1548-918X","authenticated-orcid":false,"given":"Talha","family":"Badar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Jacksonville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4534-4248","authenticated-orcid":false,"given":"Hermant S.","family":"Murthy","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Jacksonville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Punwani","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Scottsdale Arizona USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne M.","family":"Palmer","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Scottsdale Arizona USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Z.","family":"Sproat","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Scottsdale Arizona USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7627-9560","authenticated-orcid":false,"given":"Dong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaaren K.","family":"Reichard","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-8163","authenticated-orcid":false,"given":"Rong","family":"He","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Viswanatha","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0434-4965","authenticated-orcid":false,"given":"Cinthya J.","family":"Zepeda\u2010Mendoza","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-6172","authenticated-orcid":false,"given":"Naseema","family":"Gangat","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebede H.","family":"Begna","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4605-3821","authenticated-orcid":false,"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-024-02463-w"},{"issue":"5","key":"e_1_2_12_4_1","article-title":"Secondary Acute Myeloid Leukemia and Early Infection Are Independent Predictors of Poor Survival in Acute Myeloid Leukemia Treated With Hypomethylating Agents and Venetoclax","volume":"42","author":"Cordella S.","year":"2024","journal-title":"Hematology\/Oncology"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005335"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27561"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14269"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35125"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0019-y"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00878-8"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-207748"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.59"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27670"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024310"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-02016-6"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2023.2190432"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35941"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27564"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01297-0"},{"key":"e_1_2_12_21_1","article-title":"Dominant TET2 Mutations Predict Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia Patients. Front","volume":"15","author":"Hao Z.","year":"2025","journal-title":"Oncologia"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32566"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-026-01500-3"},{"issue":"1","key":"e_1_2_12_24_1","first-page":"275","article-title":"Prognostic Impact of TET2 Mutations in Patients With Acute Myeloid Leukemia: HM\u2010SCREEN\u2010Japan 01 and 02 Study","volume":"104","author":"Iyama S.","year":"2025","journal-title":"Annals of Hematology"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.2886"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01771-2"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0316-3"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281233"},{"key":"e_1_2_12_29_1","unstructured":"Institute NC \u201cAcute Myeloid Leukemia\u2014Cancer Stat Facts \u201d2026 https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html."},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01346-1"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27625"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.70443","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.70443","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.70443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:12:47Z","timestamp":1788441167000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.70443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1002\/ajh.70443"],"URL":"https:\/\/doi.org\/10.1002\/ajh.70443","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"2026-05-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}